НазадIPO Calendar: Upcoming US IPOs
Tickers, price ranges and expected dates for upcoming and recently priced US IPOs — updated weekly
31/07/2026
A running list of upcoming and recently priced US IPOs, updated weekly. Dates, price ranges and deal sizes change frequently ahead of pricing — treat the table below as a snapshot as of September 18, 2026, and confirm details before making any decision.
Upcoming and Recent IPOs
| Company | Ticker | Price Range | Est. Deal Size | Expected Date |
|---|---|---|---|---|
| Electra Therapeutics | ETRA | Priced at $15.00 | $350.0M | Priced 9/18/2026 |
| Orion180 Insurance Group | OIG | Priced at $12.00 (below $15.00–$17.00 range) | $240.0M | Priced 9/18/2026 |
| Leader's Advantage Acquisition Corp. | LEDRU | Priced at $10.00 | $150.0M | Priced 9/18/2026 |
| American Savings Bank of Hawaii | ASBH | Priced at $16.00, first-day close $17.00 | $120.0M | Priced 9/16/2026 |
| Bamboo Insurance Services | BMB | $18.00–$20.00 | $665.0M | 9/23/2026 |
| Amaero (Cross-Listing) | AMRO | $7.06 | $52.7M | 9/23/2026 |
| BW Industrial Holdings | BWGC | $6.00–$7.00 | $17.1M | Week of 9/24/2026 |
| Web3Labs Global | MDAT | $4.00–$5.00 | $28.1M | Week of 9/24/2026 |
| Encore Medical Inc. | EMI | $5.00 | $15.0M | 9/30/2026 |
What to Watch
The IPO market reopened this week after a quiet stretch, with four deals pricing between September 16 and September 18. The headline was Electra Therapeutics (ETRA), a late clinical-stage immunology and oncology biotech, which priced 23.3 million shares at $15.00 — the upper half of its $14–$16 range — to raise roughly $350 million, the largest operating-company deal of the week. Orion180 Insurance Group (OIG), a Melbourne, Florida-based excess-and-surplus homeowners insurer, priced below its marketed $15–$17 range at $12.00, raising $240 million, a sign that investor appetite for smaller insurance names is more selective than for biotech right now. Hawaii's American Savings Bank (ASBH) priced its NYSE listing at $16.00 on September 16 and closed its first day at $17.00, a modest but positive debut for the bank-holding offering. A blank-check vehicle, Leader's Advantage Acquisition Corp. (LEDRU), also priced a $150 million SPAC deal on September 18. Looking ahead, Bamboo Insurance Services (BMB) is on deck for September 23 with an $18–$20 range targeting up to $665 million, which would be the largest deal on the calendar over the next two weeks.
Off the calendar but still dominating headlines: with Anthropic's confidential S-1 still unpublished, pre-IPO speculation has moved into crypto derivatives markets. Perpetual futures tracking Anthropic's eventual public valuation traded on Hyperliquid this week at an implied market cap as high as $2.36 trillion — more than double the $965 billion price set in its May Series H round — even though no Anthropic shares yet exist to trade. Anthropic has also moved to void any unauthorized transfers of its stock ahead of a listing, including through tokenized products or special-purpose vehicles, a detail worth watching for anyone holding synthetic pre-IPO exposure.
Why It Matters for Pre-IPO and Tokenized Equity Investors
This week's mixed results — a strong reception for Electra Therapeutics against a discounted price for Orion180 — are a reminder that public IPO demand can be uneven even in an active week, and that signal feeds into the broader private-to-public pipeline that Pre-IPO and tokenized equity investors track. The Anthropic perpetual futures trading at an implied valuation above $2 trillion show there is real demand for exposure to pre-IPO AI leaders, but Anthropic's own move to void unauthorized token transfers is a pointed reminder that synthetic or tokenized exposure to a private company carries risks a public listing does not, until the underlying shares are actually registered and tradeable. Investors weighing tokenized pre-IPO exposure to Anthropic, OpenAI, or SpaceX should treat derivatives pricing as a sentiment gauge, not a guaranteed path to the eventual IPO price.
This material is for informational purposes only and does not constitute individual investment advice.
Sources
Для звонков по Таджикистану
Инвестиции
Представленная информация носит ознакомительный характер и не должна рассматриваться как предложение купить или продать иностранную валюту, ценные бумаги и/или иные финансовые инструменты. Информация, представленная на настоящем сайте, не является индивидуальной инвестиционной рекомендацией. Финансовые инструменты либо операции, упомянутые в данном разделе, могут не подходить Вам, не соответствовать Вашему инвестиционному профилю, финансовому положению, опыту инвестиций, знаниям, инвестиционным целям, отношению к риску и доходности.
ООО «Биржевой Брокер» не гарантирует и не обещает в будущем доходности вложений, не дает гарантии надежности возможных инвестиций и стабильности размеров возможных доходов. Результаты инвестирования в прошлом не являются гарантией получения доходов в будущем.
ООО «Биржевой Брокер» не несет ответственности за возможные убытки инвестора в случае совершения операций и инвестирования в финансовые инструменты, а также не гарантируют возврат, эффективность и доходность инвестиций.
Настоящим ООО «Биржевой Брокер» уведомляет о том, что ООО «Биржевой Брокер» осуществляет свою деятельность на рынке ценных бумаг в соответствии со следующими лицензиями профессионального участника рынка ценных бумаг от Министерство Финансов РТ: на осуществление депозитарной деятельности №010/25 от 25.06.2025; на осуществление брокерской деятельности №007/25 от 25.06.2025; на осуществление дилерской деятельности №008/25 от 25.06.2025 и на осуществление деятельности по управлению ценными бумагами №009/25 от 25.06.2025, а также уведомляет о существовании риска возникновения конфликта интересов, в том числе вследствие осуществления ООО «Биржевой Брокер» профессиональной деятельности на рынке ценных бумаг на условиях совмещения различных видов профессиональной деятельности.